🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for HPV

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer NCT07290621Phase 21 site📍 Chicago University of Chicago · Tests: Toripalimab, Carboplatin, Paclitaxel Provider Recommendation and HPV Vaccination NCT05365048NA1 site📍 Pasadena Kaiser Permanente · Tests: Local Tailoring implementation strategy, Prescribed Strategy Developing and Implementing HPV SCREENED NCT07657104NA2 sites📍 New Brunswick📍 Newark Rutgers, The State University of New Jersey · Tests: HPV Self-collection in the ED Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune) NCT05026138n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Multiple Human Papillomavirus Infections in the Development of CIN NCT06862102n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia · Tests: HPV vaccine Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV. A Randomized Controlled Crossover Study NCT07438080NA2 sites📍 Saint-Paul📍 Saint-Pierre Centre Hospitalier Universitaire de la Réunion · Tests: Public health workshop in community Effect of Honey For CIN II NCT06219018Phase 1, Phase 22 sites📍 Heerlen📍 Maastricht Zuyderland Medisch Centrum · Tests: Medical grade honey formulation (MGH) (L-Mesitran®) LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers NCT04665388n/a1 site📍 Toronto University Health Network, Toronto STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision NCT05576831NA1 site📍 Vancouver British Columbia Cancer Agency · Tests: Re-excision Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions NCT06658405Phase 21 site📍 Lille Centre Oscar Lambret · Tests: Human Papillomavirus 9-valent Vaccine, Recombinant Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India NCT04588402n/a1 site📍 Gangtok International Agency for Research on Cancer · Tests: The study being observational in nature, there is no intervention. The investigators will only collect cervical samples… Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer NCT05172245Phase 118 sites📍 Tampa📍 Chicago📍 Fairway National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Cisplatin, Computed Tomography, Ipatasertib Feasibility of HPV Testing With Mail-delivered Sample Collection Kits NCT07087145n/a1 site📍 San Francisco University of California, San Francisco · Tests: Mail-based Saliva Sample Kit, Study-related Surveys Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04) NCT07281430NA18 sites📍 Birmingham📍 Atlanta📍 Lafayette National Cancer Institute (NCI) · Tests: Biospecimen Collection, Cervical Biopsy, Colposcopy, Electronic Health Record Review, Endocervical Curettage A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV) NCT07601074Phase 28 sites📍 Phoenix📍 Tucson📍 Little Rock Daré Bioscience, Inc. · Tests: Lopinavir / ritonavir Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN) NCT07209189Phase 21 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Toripalimab + Chemotherapy, Toripalimab, Chemoradiotherapy or radiation A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment NCT07179315Phase 21 site📍 Chicago University of Chicago · Tests: cemiplimab+fianlimab, Cemiplimab Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study). NCT06254846NA1 site📍 Saint-Etienne Centre Hospitalier Universitaire de Saint Etienne · Tests: Urine sample, 1st stream, Cervico-vaginal swab PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer NCT06157151Phase 23 sites📍 Little Rock📍 Bethesda📍 Seattle Precigen, Inc · Tests: PRGN-2009 plus Pembrolizumab TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT06868433Phase 12 sites📍 Atlanta📍 Atlanta Emory University · Tests: Autologous Tumor Membrane Vesicles Vaccine, Biospecimen Collection, Computed Tomography, Echocardiography, Magnetic Res… Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma NCT07497607Phase 21 site📍 Cincinnati Sara Medek · Tests: Cisplatin, Radiotherapy Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme NCT05286034NA1 site📍 Carcassone International Agency for Research on Cancer · Tests: Decision aid tailored to women with lower educational attainment,accessible via artificial intelligence-based Chatbot p… Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma NCT03875716NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: Radiation therapy NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer NCT05572801NA13 sites📍 Herlev📍 Vejle📍 Aarhus Aarhus University Hospital · Tests: AMR B: HPV positive ctDNA guided imaging in follow-up De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE) NCT06307015NA1 site📍 Saint Leonards Royal North Shore Hospital · Tests: De-escalation, Standard of care Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population NCT06997068Phase 21 site📍 Rochester Mayo Clinic · Tests: Celecoxib, Erlotinib Hydrochloride, Imaging Procedure, Interview, Methotrexate A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma NCT07768189Phase 3111 sites📍 Huntsville📍 Tucson📍 Duarte Corbus Pharmaceuticals Inc. · Tests: CRB-701, capcitabine, Cetuximab (EGFR inhibitor), Docetaxel De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers NCT06554158NA1 site📍 Washington D.C. Georgetown University · Tests: Radiation Therapy A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer NCT06319963Phase 1, Phase 24 sites📍 Orlando📍 Tampa📍 Tampa Theravectys S.A. · Tests: Two IM injections Lenti-HPV-07, One IM injection Lenti-HPV-07 Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine NCT05371353n/a2 sites📍 Yangchun📍 Mianyang Shanghai Bovax Biotechnology Co., Ltd.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy